Skip to content
value.today

Sympara Medical, Inc.

Total raised
$13 M
3 rounds on record
Latest round
$3 M
Dec 2014
First round on record
Mar 2013
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sympara Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2014$3 MNo. 3$2 to $10 million

Sympara Medical, Inc.: Raise no. 3, Dec 2014

Investors in this round

5 investors had bought by the notice of Dec 22, 2014: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marc-Henri Galletti · Executive Officer, Director
  • Andrew Cleeland · Director
  • Juliet Bakker · Director
  • Ross Jaffe · Director
  • Uday Kumar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$4,041,300 worth of Series A-1 Preferred Stock and $16,000 worth of Warrants to Purchase Common Stock”

Signed by Marc-Henri Galletti, President and CEO. Newest notice filed Dec 22, 2014. Read the notice at the SEC.

equity, optionsSEC
Oct 2014$6 MNo. 2$2 to $10 million

Sympara Medical, Inc.: Raise no. 2, Oct 2014

Investors in this round

6 investors had bought by the notice of Oct 23, 2014: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marc N Galletti · Executive Officer
  • Randolf von Oepen · Executive Officer
  • Andrew Cleeland · Director
  • Juliet N Bakker · Director
  • Ross N Jaffe · Director
  • Uday N Kumar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Marc Galletti, Chief Executive Officer. Newest notice filed Oct 23, 2014. Read the notice at the SEC.

equitySEC
Mar 2013$4 MNo. 1$2 to $10 million

Sympara Medical, Inc.: Raise no. 1, Mar 2013

Investors in this round

4 investors had bought by the notice of Apr 2, 2013: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kelly J McCrystle · Executive Officer
  • Kevin J Ehrenreich · Executive Officer, Director
  • Randolf J von Oepen · Executive Officer
  • Andrew J Cleeland · Director
  • Juliet N Bakker · Director
  • Ross N Jaffe · Director
  • Uday N Kumar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin J. Ehrenreich, President & CEO. Newest notice filed Apr 2, 2013. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sympara Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2014).

    SEC Form D · Dec 2014

  • The industry group it chose in its notices: Other.

    SEC Form D · Dec 2014

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sympara Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sympara Medical, Inc.
NameRoleNamed in
Marc-Henri GallettiExecutive officerDec 2014
Marc N GallettiExecutive officerOct 2014
Randolf von OepenExecutive officerOct 2014
Kelly J McCrystleExecutive officerApr 2013
Kevin J EhrenreichExecutive officerApr 2013
Randolf J von OepenExecutive officerApr 2013
Andrew CleelandDirectorDec 2014
Juliet BakkerDirectorDec 2014
Marc-Henri GallettiDirectorDec 2014
Ross JaffeDirectorDec 2014
Uday KumarDirectorDec 2014
Juliet N BakkerDirectorOct 2014
Ross N JaffeDirectorOct 2014
Uday N KumarDirectorOct 2014
Andrew J CleelandDirectorApr 2013
Kevin J EhrenreichDirectorApr 2013